Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
AUTOR(ES)
Levinson, S S
RESUMO
An anti-C1q capture method kit (C1q-immunoglobulin G [IgG]) (Ortho Diagnostics, Inc., Raritan, N.J.) for measuring circulating immune complexes (CIC) was evaluated. The kit showed poor diagnostic sensitivity (P less than 0.005) for identifying CIC in patients with systemic lupus, rheumatoid arthritis, and bacterial endocarditis, as compared with polyethylene glycol-IgG and Raji cell tests (12, 24, and 24 positive, respectively, of 31 patients). Of the patients who were positive with the C1q-IgG test, 25% showed discrepancies when their results were compared with the polyethylene glycol-IgG and C1q-binding test results. Gel filtration chromatography of two of these discrepant sera showed the only peak of C1q-IgG activity to be associated with monomeric IgG (molecular weight, less than 200,000). We concluded that the kit method may be measuring substances other than CIC in some sera, because molecules of C1q attached to IgG should exhibit a molecular weight of greater than 500,000.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=269275Documentos Relacionados
- Fluorescent anti-immunoglobulin G assay of circulating immune complexes extracted with polyethylene glycol.
- Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes
- Anticorpos antinucleossomo e anti-C1q no lúpus eritematoso sistêmico juvenil
- Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus
- Circulating Immune Complexes in Lyme Arthritis: DETECTION BY THE 125I-C1q BINDING, C1q SOLID PHASE, AND RAJI CELL ASSAYS
